Showing results (301-310 of 420) with videos related to

Sort By:
Pageof 42
Leukemia Research|January 1, 1991
Unexpected immunoglobulin light chain gene rearrangements in myeloid antigen positive acute lymphoid leukemiaE Paietta, B Van Ness, J M Bennett, et al.
The American Journal of Cardiology|February 1, 1981
Delayed pericardial disease after radiotherapyM M Applefeld, R G Slawson, M Hall-Craigs, et al.
Cancer|April 15, 1984
Acute anthracycline cardiotoxicity. Comparative morphologic study of three analoguesA L Taylor, M M Applefeld, P H Wiernik, et al.
Clinical Pharmacy|November 1, 1982
Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patientsF J Danhauer, C L Fortner, S C Schimpff, et al.
Cancer Clinical Trials|January 1, 1981
Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinomaJ Z Fuks, D A Van Echo, J Aisner, et al.
Neurology|March 1, 1989
Taxol produces a predominantly sensory neuropathyR B Lipton, S C Apfel, J P Dutcher, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1977
Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patientsD M Hahn, S C Schimpff, V M Young, et al.
Leukemia|December 9, 1998
Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experienceE Paietta, J Racevskis, J M Bennett, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1978
Infection in acute leukemia patients receiving oral nonabsorable antibioticsD M Hahn, S C Schimpff, C L Fortner, et al.
Cancer Research|May 1, 1983
Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugsC H Park, P H Wiernik, F S Morrison, et al.
Pageof 42